Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Company Description
American Greetings designs, manufactures and sells greeting cards and other social expression products in the United States and internationally. The company provides greeting cards, gift packaging products, party goods, stationery, giftware, and custom display fixtures. The company distributes its products through mass merchandisers, chain drug stores, supermarkets, card and gift shops, department stores, military post exchanges, variety stores, and combo stores, as well as through its Website Cardstore.com. American Greetings was founded in 1906 and is headquartered in Cleveland, Ohio.
American Greetings Big Miss
The most recent quarter saw the company miss the Zacks Consensus Estimate by a large amount. The company reported a loss of $0.05 per share while the consensus estimate was calling for a gain of $0.48. That translates to a $0.53 miss or 110%. The stock fell 2% in the session following the release.
Stock Sees Institutional Selling
Marathon Asset Management recently sold 1.4M shares of AM. The asset manager still holds 1.3M shares and is now below the 5% 13G filing requirement at 4.6% ownership. This type of institutional selling does not bode well for the company despite the fact that its management is looking at an LBO.
American Greetings Sees Estimates Moving Lower
Estimates for American Greetings have been sinking of late. The Zacks Consensus Estimate for 2013 for AM stood at $2.10 as of February 2012. The consensus has since moved lower to $0.80. Over the same time period estimates for 2014 have moved from $2.93 to $2.35. The implied earnings growth rate is negative, and not what an investor wants to see.
Valuation
The valuation metrics for AM are low, but don't think there is a lot of value in this stock. The trailing PE of 8x is less than half the 17x industry average, while the forward PE of 20x has the company trading at a premium to the industry average of 15x. Price to book of 0.8x is well below the 4x industry average and price to sale is also quite low at 0.3x compared to 1.3x industry average.
The Chart
The stock has been stuck around the $17 level due to a September 2012 announcement that management was looking to buy the company. Only recently have investors started to sell the stock in the face of a rising market with AM seeing significant competition and lower earnings. The stock is a Zacks Rank #5 (Strong Sell)
Brian Bolan is a Stock Strategist for Zacks.com. He is the Editor in charge of the Zacks Home Run Investor service, a Buy and Hold service where he recommends the stocks in the portfolio
Brian is also the editor of Follow The Money Trader a trading service that tracks institutional money flows and looks for great stock picks from that data.
Follow Brian Bolan on twitter at @BBolan1
Like Brian Bolan on Facebook
Read the full on AM